The short answer
Welireg (Belzutifan) is a targeted therapy called a HIF-2 alpha inhibitor. It blocks a protein called HIF-2 alpha that some kidney cancers and von Hippel-Lindau tumors use to grow and form blood vessels. It is used to help treat certain kidney cancers, some tumors linked to von Hippel-Lindau disease, and pheochromocytoma or paraganglioma, and is usually given as tablets taken by mouth each day. Like all cancer medicines it can cause side effects; this page explains the common ones and the warning signs to report. It is educational only and not a substitute for your care team's advice.
Welireg is the brand name; its generic name is belzutifan.
It is a targeted therapy called a HIF-2 alpha inhibitor — it blocks a protein called HIF-2 alpha that some kidney cancers and von Hippel-Lindau tumors use to grow and form blood vessels.
It is used to help treat certain kidney cancers, tumors linked to von Hippel-Lindau disease, and pheochromocytoma or paraganglioma.
It is usually given as tablets taken by mouth each day.
Choose how you want to read this
The whole article, with every detail and caution.
This page explains Welireg (belzutifan), a daily tablet for certain kidney cancers and related tumors. It is for patients who have been prescribed it and the people who help them.
A pill that turns down a stuck oxygen switch
Welireg is the brand name. Belzutifan is the generic name. It blocks HIF-2 alpha, a protein that normally switches on when a cell runs short of oxygen. In von Hippel-Lindau disease, and in clear cell kidney cancer, that switch gets jammed on. The cell behaves as though it is starved of oxygen. It builds blood vessels and it grows. Belzutifan turns the signal down.
The label's adult amount is 120 mg by mouth once a day, with or without food. Some children weighing less than 40 kg take a lower amount. The prescription your own team writes takes precedence. Anemia and low oxygen levels often prompt them to reduce it or pause. Treatment carries on until the cancer grows or the side effects become too much. After kidney surgery, it is given for up to 54 weeks.
Who belzutifan is approved for
The label covers four groups of patients:
- Von Hippel-Lindau disease in adults, where the condition has caused kidney cancer, a brain or spine hemangioblastoma, or a pancreatic neuroendocrine tumor that needs treatment.
- Clear cell kidney cancer after surgery, given with pembrolizumab, when the risk of return is intermediate-high or high.
- Advanced clear cell kidney cancer, on its own, after both a PD-1 or PD-L1 drug and a VEGF-targeted tablet have already been used.
- Pheochromocytoma and paraganglioma, rare tumors of the adrenal gland and nearby nerve tissue, from age 12 upward. This is for tumors that have spread or cannot be removed with surgery.
The boxed warning is about pregnancy and birth control
Before you start, there is one serious warning to know about. The single boxed warning on this label concerns an unborn baby. Belzutifan can cause harm in pregnancy. A pregnancy test is needed before the first dose.
There is a twist that matters. This drug can stop hormonal birth control from working. So the label asks for effective non-hormonal contraception. The pill, the patch and hormonal coils cannot be relied on here. The label asks for birth control until 1 week after the last dose. This applies to men with partners who could become pregnant too. Ask your team exactly what to use.
Anemia and low oxygen shape the monitoring
Anemia, a shortage of red blood cells, is the most common problem. That is no accident. The protein this drug blocks also drives red blood cell production. Hemoglobin is measured before treatment starts and at intervals after. Some people need a transfusion, a dose reduction, or a pause.
The second issue is hypoxia, meaning low oxygen in the blood. Oxygen levels are checked before and during treatment. The warning signs to report are listed in the next sections.
How to take it day to day
Swallow the tablets whole. Do not chew, crush or split them. Take them at roughly the same time each day.
The label gives two rules people often ask about. If you miss a dose, you can take it later the same day, then go back to your normal time the next day. Never double up. If you are sick after a dose, do not take a replacement. Wait for the next day's dose.
Ask before starting any new medicine, including ones bought without a prescription. Some change how much belzutifan reaches your blood.
When to get help sooner
- Call 911 or go to an emergency department if you are gasping for breath at rest, or your lips or fingertips look blue or grey. The same applies if you faint, or you get chest pain or pressure. Severe hypoxia is one of the two problems this drug is monitored for. Chest pain always needs emergency assessment rather than a phone call. Do not drive yourself.
- Call your care team right away if you become breathless doing things you used to manage easily, your heart pounds, or you feel light-headed. Do not push through it and wait for the next blood test. Being so pale and drained you cannot climb the stairs points the same way.
- Call your care team right away if you think you might be pregnant. Call too if you have been relying on the pill, a patch or a hormonal coil. Belzutifan can stop hormonal birth control working, and the boxed warning is about harm to an unborn baby.
Sources
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=13e15ee0-d679-4fa9-9430-e2e2170474da
https://www.cancer.gov/about-cancer/treatment/drugs/belzutifan
Common questions
What is Welireg?
Welireg (Belzutifan) is a targeted therapy called a HIF-2 alpha inhibitor. It blocks a protein called HIF-2 alpha that some kidney cancers and von Hippel-Lindau tumors use to grow and form blood vessels. It is used to help treat certain kidney cancers, tumors linked to von Hippel-Lindau disease, and pheochromocytoma or paraganglioma.
How is Welireg given?
It is usually given as tablets taken by mouth each day. It is taken once a day at home. Take it exactly as prescribed and ask your team before stopping or changing it. The exact schedule is set by your care team.
What are the common side effects of Welireg?
Commonly reported side effects include anemia (low red blood cells), tiredness, dizziness, nausea, and headache. Not everyone gets them, and many can be managed. Tell your care team about anything new or worsening.
Does Welireg cure cancer?
That depends on the person, the cancer type, and its stage. For some people a medicine like this can control cancer for a long time or be part of a curative plan; for others the goal is to slow the cancer or ease symptoms. Your care team can explain the goal in your situation.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Talk with a trained specialist or navigator
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-07-14 what this meansLast updated: 2026-09-29Next planned review: 2027-01-14
Review details and limits
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Editorial review complete. This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Words to know
Tap any term to see what it means.
Knowledge check
0 of 2 answered
This self-assessment checks understanding of educational content only. It is not medical advice.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Editorial review complete — This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.